![Miltenyi looks to offer ‘top-to-bottom’ services as tech meets CDMO Miltenyi looks to offer ‘top-to-bottom’ services as tech meets CDMO](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/bltaf0c2b75d7c3e556/658ca416c6ab6d040a0ae21e/miltenyi-1-scaled.jpg?width=1280&auto=webp&quality=95&format=jpg&disable=upscale)
Date: Oct 3, 2022
Duration: 20 Min
Miltenyi Biotec says it is uniquely placed in the advanced therapy space to support developers with the full gamut of technologies and chemical/biological substances.
Founded in 1989, Miltenyi has moved from a cell separation firm into a full cell and gene services firm, offering a host of services including as a contract development and manufacturing organization (CDMO).
“What makes Miltenyi unique is we not only supply the expertise from both the technological, biological and even regulatory expertise, but we have best-in-class reagents, cytokines, media, instrumentation, and we utilize all that.
“It’s all proprietary […] nobody knows our technology better than us so we can apply all of that to that CDMO services, and it’s Miltenyi from top-to-bottom,” said Cliff Ramsdell, senior marketing product manager at Miltenyi Biotec.